IL4 and neoplasm: Although IL-4 is typically described as an inducer of a type-2 immune response [33], local delivery of IL-4 at an immunization site induced IL-12 production by antigen-presenting cells, and Th1-type responses in our pre-clinical tumor vaccine model [34] as well as in an infectious disease (Leishmania major) model [35].